Introduction: Knowledge about oesophageal carcinoids is based primarily on case reports, and therefore information about them is incomplete.
Introduction
Endocrine tumours of the gastrointestinal tract, which are known as carcinoids, herein collectively termed neuroendocrine tumours (NETs), originate from the diffuse neuroendocrine cell system [1] . Typical carcinoid, atypical carcinoid, small cell neuroendocrine carcinoma, and large cell neuroendocrine carcinoma are subgroups of neuroendocrine tumours [2] . The traditional term of carcinoid is not adequate to cover all NETs [3] . Over 90% of all carcinoid tumours originate in the gastrointestinal tract, and most carcinoid tumours are gastrointestinal in origin, but they only account for 1.5% of all gastrointestinal neoplasms [4] . Neuroendocrine tumours of the oesophagus are very rare and represent only 0.05% of all gastrointestinal NETs [5] and therefore are one of the rarest of all carcinoid tumours [6] . Brenner et al. were the first researchers to describe a carcinoid originating within the oesophagus [7] . Diagnosis of oesophageal carcinoid can be suggested by barium meal, endoscopy with biopsy, and computed tomography scanning [3] . Nowadays, somatostatin analogues play a fundamental role in the treatment of NETs of the gastrointestinal tract [8] . Because knowledge about oesophageal carcinoid is based primarily on case reports, the treatment of choice has not been established [6, 9] . We found a lack of adequate basic data about oesophageal carcinoid even in reference books such as Robbins and Cotran Pathologic Basis of Disease [10] or Odze & Goldblum Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas [11] .
Aim
Based on this vague and incomplete information, we aimed to collect information on oesophageal carci-noid tumours in a systematic review study. We used the term carcinoid for typical carcinoid tumours or well-differentiated neuroendocrine tumours.
Material and methods

Search strategies
Three databases (PubMed, Scopus, and Web of Science) were searched for the characteristics of carcinoid tumour of oesophagus using the term "carcinoid" combined with "oesophageal" for publications with English abstracts.
Study selection
One author (M.S) searched the studies, and then a second author (M.R) who was blinded to the first author. The disagreement between two authors was resolved with a two-way conversation. Studies included: 1) original articles, case series, or case reports; 2) reporting at least one of the characteristics of benign carcinoid tumour or carcinoid tumour.
Data extraction
Name of first author, year of publication, number of patients, age, sex, tumour size, tumour behaviour, signs and symptoms; tumour site, and additional findings were extracted for every study.
Results
Out of 670 studies searched, 18 studies were assessed for eligibility. Four studies were excluded, and therefore 14 studies [4, 6, 7, 9, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] were included and analysed in the systematic review ( Figure 1 ).
Fourteen studies from 1968 to 2016 included 19 patients with carcinoid tumour; 11 (57.9%) patients were male and 8 (42.1%) patients were female (Table I) . The mean age at diagnosis was 55.5 years (range: 26-82 years). The mean tumour size was 2.44 cm (range: 0.3-12 cm). Out of nine studies reporting behaviour of the tumour, six studies (66.7%) had non-aggressive behaviour. Out of 11 studies reporting signs of tumour, six (54.5%), four (36.4%), three (27.3%), one (9%), one (9%), one (9%), and one (9%) cases had a history of dysphagia, weight loss, heartburn, lassitude and fatigue, gastrointestinal bleeding, epigastric soreness, and no symptoms, respectively. Out of 15 cases reporting the tumor site, the lower oesophagus was in 12 (80%), the upper oesophagus in 2 (13.3%), and the middle oesophagus in one (6.7%).
Discussion
This study reported a number of characteristics of oesophageal carcinoid that were ambiguous in reference books and sources. A review in early 2017 included a total of 1574 oesophageal cancers; 14 (0.89%) were cases of neuroendocrine neoplasm and 1/14 (7.1%) had oesophageal carcinoid [2] . Hoang et al. [6] included 13 patients who were diagnosed as upper gastrointestinal carcinoid tumours, of which just 1 (7.7%) patient had oesophageal carcinoid, and in another study this figure was 7.9% [22] .
Lindberg et al. [3] concluded that most NET patients are male, mainly in the sixth to seventh decade of life. Neuroendocrine tumours of the oesophagus are typically located in the distal half of the organ. They show no special hormonal syndrome, but present with clinical features that are also common to the other types of oesophageal cancer, i.e. dysphagia, severe weight loss, and sometimes chest pain [1] . The NET tumours are usually of large size (> 4 cm) [3] .
Studies reported before 1990 showed that oesophageal carcinoid usually occurs in the lower oesophagus, with a male-to-female ratio of 6 : 1 [23, 24] , who presented most commonly with dysphagia, weight loss, pain, reflux esophagitis, fatigue, and melanotic stools. This study reported that the age at diagnosis of oesophageal carcinoid ranged from 30 to 82 years [23] . Lesions of oesophageal carcinoids are typically large, polypoid, and confined to the submucosa or lamina propria [25] . In one of the reference books [11] it was mentioned that carcinoid tumours are uncommon in the oesophagus, and these cases showed a male predominance, and most of them were distal, particularly at the gastroesophageal junction. Fifty per cent of them were metastatic at the time of diagnosis. This disease is very rare, and therefore the number of reported patients is low in the present study. In the literature the definition of carcinoid in the studies was different.
Conclusions
This meta-analysis showed that the mean age at diagnosis was 55.5 years (range: 26-82 years). The tumour was around 1.4 times more prevalent in males and located mainly in the distal (lower) oesophagus. The mean tumour size was 2.4 cm (range: 0.3-12 cm) and the most tumours were non-secretor. The main symptoms of this disease were dysphagia, weight loss, and reflux. The tumour behaviour was mainly non-aggressive except for cases associated with adenocarcinoma. 
